Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled dose-finding study of YZD-27 for acute ischemic stroke
CTR20262497Phase 2Active
- Sponsor
- 西安秦申嘉合药物研究
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in ischemic stroke comparing YZD-27 arm with Placebo arm (2 arms). Primary endpoint: Proportion of participants with modified Rankin Scale score 0 to 1 at Day 90. Started Jul 2026; status: active.
02
Drugs
YZD-27
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on CTR20262497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262497.